S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
CVE:THCX

The Hydropothecary Stock Forecast, Price & News

C$5.30
+0.33 (+6.64 %)
(As of 06/21/2018)
Add
Compare
Today's Range
C$5.00
C$5.37
50-Day Range
C$5.30
C$5.30
52-Week Range
C$1.10
C$5.42
Volume5.38 million shs
Average Volume2.35 million shs
Market CapitalizationC$949.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive THCX News and Ratings via Email

Sign-up to receive the latest news and ratings for The Hydropothecary and its competitors with MarketBeat's FREE daily newsletter.


The Hydropothecary logo

About The Hydropothecary

The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$949.11 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












The Hydropothecary (CVE:THCX) Frequently Asked Questions

What stocks does MarketBeat like better than The Hydropothecary?

Wall Street analysts have given The Hydropothecary a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Hydropothecary wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are The Hydropothecary's key executives?

The Hydropothecary's management team includes the following people:
  • Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 34)
  • Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 34)
  • Mr. Ed Chaplin, CFO & Corp. Sec. (Age 48)
  • Mr. James McMillan, VP of Bus. Devel. (Age 50)
  • Mr. Arno Groll, Director of Operations

What other stocks do shareholders of The Hydropothecary own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Hydropothecary investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), (CGC), Cronos Group (CRON), CannTrust (CTST), Funko (FNKO), (HEXO), Riot Blockchain (RIOT) and Unrivaled Brands (TRTC).

What is The Hydropothecary's stock symbol?

The Hydropothecary trades on the Canadian Venture Exchange (CVE) under the ticker symbol "THCX."

How do I buy shares of The Hydropothecary?

Shares of THCX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is The Hydropothecary's stock price today?

One share of THCX stock can currently be purchased for approximately C$5.30.

How much money does The Hydropothecary make?

The Hydropothecary has a market capitalization of C$949.11 million.

What is The Hydropothecary's official website?

The official website for The Hydropothecary is www.thehydropothecary.com.

Where are The Hydropothecary's headquarters?

The Hydropothecary is headquartered at 120 Ch de la Rive, GATINEAU, QC J8M 1V2, Canada.

How can I contact The Hydropothecary?

The Hydropothecary's mailing address is 120 Ch de la Rive, GATINEAU, QC J8M 1V2, Canada. The company can be reached via phone at +1-416-7504949.


This page was last updated on 10/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.